These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 14578336)

  • 1. Effect of anticoagulants and cell separation media as preanalytical determinants on zymographic analysis of plasma matrix metalloproteinases.
    Mannello F; Luchetti F; Canonico B; Papa S
    Clin Chem; 2003 Nov; 49(11):1956-7. PubMed ID: 14578336
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of anticoagulants on the activity of gelatinases.
    Castellazzi M; Tamborino C; Fainardi E; Manfrinato MC; Granieri E; Dallocchio F; Bellini T
    Clin Biochem; 2007 Nov; 40(16-17):1272-6. PubMed ID: 17904541
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kind of sample as preanalytical determinant of matrix metalloproteinase 2 and 9 and tissue inhibitor of metalloproteinase 2 in blood.
    Jung K; Laube C; Lein M; Lichtinghagen R; Tschesche H; Schnorr D; Loening SA
    Clin Chem; 1998 May; 44(5):1060-2. PubMed ID: 9590387
    [No Abstract]   [Full Text] [Related]  

  • 4. Serum or plasma samples? The "Cinderella" role of blood collection procedures: preanalytical methodological issues influence the release and activity of circulating matrix metalloproteinases and their tissue inhibitors, hampering diagnostic trueness and leading to misinterpretation.
    Mannello F
    Arterioscler Thromb Vasc Biol; 2008 Apr; 28(4):611-4. PubMed ID: 18354094
    [No Abstract]   [Full Text] [Related]  

  • 5. Levels of matrix metalloproteinases differ in plasma and serum - aspects regarding analysis of biological markers in cancer.
    Jonsson A; Hjalmarsson C; Falk P; Ivarsson ML
    Br J Cancer; 2016 Sep; 115(6):703-6. PubMed ID: 27187685
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preanalytical biases in measurement of matrix metalloproteinases and their tissue inhibitors in peripheral blood.
    Jung K
    J Rheumatol; 2007 Apr; 34(4):890-2; author reply 892. PubMed ID: 17407248
    [No Abstract]   [Full Text] [Related]  

  • 7. Sample processing and its preanalytical impact on the measurement of circulating matrix metalloproteinases.
    Jung K
    Clin Chem Lab Med; 2006; 44(4):500-2. PubMed ID: 16599848
    [No Abstract]   [Full Text] [Related]  

  • 8. Matrix metalloproteinases (MMP): determination of different forms by different techniques may require different preanalytical strategies.
    Fainardi E; Castellazzi M; Bellini T; Dallocchio F
    Mult Scler; 2007 May; 13(4):561-2. PubMed ID: 17463079
    [No Abstract]   [Full Text] [Related]  

  • 9. Matrix metalloproteinases (MMP): determination of different forms by different techniques may require different preanalytical strategies.
    Fainardi E; Castellazzi M; Bellini T; Dallocchio F
    Mult Scler; 2007 Jun; 13(5):691-2. PubMed ID: 17615626
    [No Abstract]   [Full Text] [Related]  

  • 10. Matrix metalloproteinases do not properly work as peripheral blood biomarkers without taking into account the preanalytical impact of blood sampling.
    Jung K
    Eur J Cardiothorac Surg; 2008 May; 33(5):944; author reply 945. PubMed ID: 18343680
    [No Abstract]   [Full Text] [Related]  

  • 11. Consideration of preanalytical impact of blood sampling on measurement of matrix metalloproteinases and their inhibitors as precondition to evaluate their relationship to clinical data.
    Jung K
    Mult Scler; 2009 Nov; 15(11):1372-3; author reply 1374-5. PubMed ID: 19965559
    [No Abstract]   [Full Text] [Related]  

  • 12. The 'never-ending story' of the influence of blood specimen collection methods affecting the concentration, the zymographic profile and the usefulness of matrix metalloproteinases and their tissue inhibitors in multiple sclerosis diagnosis/prognosis: a landmark for limiting the misuse of serum samples.
    Mannello F; Tonti GA; Canestrari F
    Mult Scler; 2007 Jun; 13(5):687-90. PubMed ID: 17548455
    [No Abstract]   [Full Text] [Related]  

  • 13. Influence of blood sampling procedure on plasma concentrations of matrix metalloproteinases and their tissue inhibitors.
    Rossignol P; Cambillau M; Bissery A; Mouradian D; Benetos A; Michel JB; Plouin PF; Chatellier G; Jacob MP
    Clin Exp Pharmacol Physiol; 2008 Apr; 35(4):464-9. PubMed ID: 18307742
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blood sampling as critical preanalytical determinant to use circulating MMP and TIMP as surrogate markers for pathological processes.
    Jung K; Meisser A; Bischof P
    Int J Cancer; 2005 Oct; 116(6):1000-1; author reply 1002-3. PubMed ID: 15856460
    [No Abstract]   [Full Text] [Related]  

  • 15. Behaviour of the plasma concentration of gelatinases and their tissue inhibitors in subjects with venous leg ulcers.
    Caimi G; Ferrara F; Montana M; Muratori I; Amato C; Canino B; Lo Presti R; Hopps E
    Clin Hemorheol Microcirc; 2015; 60(3):309-16. PubMed ID: 25159491
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Specific temporal profile of matrix metalloproteinase release occurs in patients after myocardial infarction: relation to left ventricular remodeling.
    Webb CS; Bonnema DD; Ahmed SH; Leonardi AH; McClure CD; Clark LL; Stroud RE; Corn WC; Finklea L; Zile MR; Spinale FG
    Circulation; 2006 Sep; 114(10):1020-7. PubMed ID: 16923753
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Release of matrix metalloproteinases following alcohol septal ablation in hypertrophic obstructive cardiomyopathy.
    Bradham WS; Gunasinghe H; Holder JR; Multani M; Killip D; Anderson M; Meyer D; Spencer WH; Torre-Amione G; Spinale FG
    J Am Coll Cardiol; 2002 Dec; 40(12):2165-73. PubMed ID: 12505230
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and biological evaluation of curcuminoid pyrazoles as new therapeutic agents in inflammatory bowel disease: effect on matrix metalloproteinases.
    Claramunt RM; Bouissane L; Cabildo MP; Cornago MP; Elguero J; Radziwon A; Medina C
    Bioorg Med Chem; 2009 Feb; 17(3):1290-6. PubMed ID: 19128977
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiopulmonary bypass induces the synthesis and release of matrix metalloproteinases.
    Joffs C; Gunasinghe HR; Multani MM; Dorman BH; Kratz JM; Crumbley AJ; Crawford FA; Spinale FG
    Ann Thorac Surg; 2001 May; 71(5):1518-23. PubMed ID: 11383793
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Production of matrix metalloproteinases by cultured bovine theca and granulosa cells.
    Smith MF; Gutierrez CG; Ricke WA; Armstrong DG; Webb R
    Reproduction; 2005 Jan; 129(1):75-87. PubMed ID: 15615900
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.